NewsBenzingaB. Riley Securities réitère son conseil d’achat sur Wave Life Sciences et abaisse son objectif de cours à 18 $ B. Riley Securities réitère son conseil d’achat sur Wave Life Sciences et abaisse son objectif de cours à 18 $ Benzinga 2026.11.09 15:10 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?